CINECA IRIS Institutional Research Information System

BENDINELLI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.569
AS - Asia 3.561
EU - Europa 3.490
SA - Sud America 476
AF - Africa 243
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.348
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.322
CN - Cina 1.217
SG - Singapore 1.113
IT - Italia 827
DE - Germania 689
SE - Svezia 647
HK - Hong Kong 492
BR - Brasile 420
BG - Bulgaria 293
GB - Regno Unito 249
TR - Turchia 222
CA - Canada 219
UA - Ucraina 184
KR - Corea 169
RU - Federazione Russa 162
VN - Vietnam 158
FI - Finlandia 135
CI - Costa d'Avorio 127
CH - Svizzera 81
AT - Austria 80
IN - India 55
FR - Francia 43
BE - Belgio 38
SN - Senegal 30
MA - Marocco 29
JP - Giappone 22
NG - Nigeria 22
BD - Bangladesh 17
AR - Argentina 16
PK - Pakistan 14
IQ - Iraq 12
PL - Polonia 10
CO - Colombia 9
ID - Indonesia 9
ZA - Sudafrica 9
ES - Italia 8
MX - Messico 8
RO - Romania 8
VE - Venezuela 8
EC - Ecuador 7
KE - Kenya 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AU - Australia 6
CL - Cile 6
AL - Albania 5
BJ - Benin 5
LT - Lituania 5
OM - Oman 5
UY - Uruguay 5
JM - Giamaica 4
KZ - Kazakistan 4
PT - Portogallo 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
IL - Israele 3
MY - Malesia 3
NL - Olanda 3
PS - Palestinian Territory 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BS - Bahamas 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
PY - Paraguay 2
RS - Serbia 2
BB - Barbados 1
BN - Brunei Darussalam 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
Totale 15.338
Salva come PNG Salva come JPEG
Città #
Woodbridge 747
Ashburn 727
Ann Arbor 692
Chandler 649
Singapore 641
Fairfield 539
Houston 533
Santa Clara 516
Hong Kong 489
Milan 297
Sofia 292
Beijing 251
Jacksonville 246
Dallas 243
Hefei 225
Shanghai 223
Seattle 204
Ottawa 189
Wilmington 177
New York 176
Seoul 166
Cambridge 159
Izmir 156
Florence 129
Abidjan 127
Princeton 115
Boardman 110
Nanjing 107
Lawrence 104
Los Angeles 96
Medford 95
Serra 93
Bern 80
Vienna 73
Des Moines 63
Dearborn 55
Dong Ket 52
Buffalo 48
Istanbul 45
Columbus 38
Brussels 36
Council Bluffs 36
Jüchen 36
The Dalles 36
Lancaster 35
Redondo Beach 35
San Diego 35
Kunming 31
Munich 31
Dakar 30
Nanchang 30
Bremen 27
Ho Chi Minh City 27
Casablanca 26
Frankfurt am Main 25
São Paulo 25
London 23
Changsha 22
Lagos 22
Düsseldorf 20
Boulder 19
Redwood City 19
Hebei 18
Shenyang 18
Belo Horizonte 17
Toronto 17
Turku 16
Tokyo 15
Pune 14
Rio de Janeiro 14
Guangzhou 13
Norwalk 13
Porto Alegre 13
Rome 13
Falls Church 12
Hanoi 12
Jiaxing 12
Orange 12
Ogden 11
Pisa 11
Curitiba 10
Quanzhou 10
Salvador 10
San Jose 10
Tianjin 10
Chicago 9
Fuzhou 9
Jinan 9
Nürnberg 9
Washington 9
Brooklyn 8
Chennai 8
Hangzhou 8
Helsinki 8
Warsaw 8
Nairobi 7
Phoenix 7
Tashkent 7
Falkenstein 6
San Francisco 6
Totale 11.012
Salva come PNG Salva come JPEG
Nome #
Detection of feline immunodeficiency virus (FIV) p24 antigen and specific p24-antibodies by monoclonal antibody-based assays 258
Feline Immunodeficiency virus (FIV)-associated nephropathy in domestic cats: An animal model of HIV-nephropathy 256
Renal involvement in feline immunodeficiwency virus infection 206
Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes 206
IMMUNODEPRESSION BY ROWSON-PARR VIRUS IN MICE - EFFECT OF ROWSON-PARR VIRUS AND FRIEND LEUKEMIA COMPLEX INFECTIONS ON BACKGROUND ANTIBODY-FORMING-CELLS TO VARIOUS ERYTHROCYTES 205
Effects of feline immunodeficiency virus on feline monocyte-derived dendritic cells infected by spinoculation 205
Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity 205
The effects of feline immunodeficiency virus on feline monocyte derived dendritic cells infected by spinoculation. 204
Feline immunodeficiency virus (FIV) genome in peripheral blood mononuclear cells of FIV-seronegative cats 202
Defective natural killer cell cytotoxic activity in feline immunodeficiency virus-infected cats 202
Effect of feline immunodeficiency virus on feline monocyte-derived dendritic cells derived for in vivo use. 201
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts 198
IMMUNODEPRESSION BY ROWSON-PARR VIRUS IN MICE - EFFECT OF ROWSON-PARR VIRUS AND FRIEND LEUKEMIA COMPLEX INFECTIONS ON CONTACT SENSITIVITY IN SUSCEPTIBLE AND RESISTANT MICE 197
EFFECT OF ADULT PERITONEAL CELLS ON ANTIBODY RESPONSE OF NEWBORN MICE TO SHEEP RED BLOOD CELLS 195
IDENTIFICATION OF A LINEAR NEUTRALIZATION SITE WITHIN THE 3RD VARIABLE REGION OF THE FELINE IMMUNODEFICIENCY VIRUS ENVELOPE 195
DEPRESSION OF HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES BY COXSACKIE-VIRUSES IN MICE 192
Circulating immune complexes and analysis of renal immune deposits in FIV-infected cats 191
Renal involvement in feline immunodeficiency virus infection: a clinicopathological study 189
A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein 187
La saliva come sotituto del siero nella diagnosi di laboratorio dell'infezione da FIV 186
Immunogenicity of a fixed cell FIV vaccine in field cats 185
Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats 184
DETECTION OF B-EPITOPES ON THE P24 GAG PROTEIN OF FELINE IMMUNODEFICIENCY VIRUS BY MONOCLONAL-ANTIBODIES 183
Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine 181
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats 179
Circulating immune-complexes and analysis of renal immune deposits in Feline Immunodeficiency Virus-infected Cats 178
Development Of A Self-Inactivating Bicistronic Lentiviral Vector For Heterologous Primary Cells Transduction, 177
Renal involvement in Feline Immunodeficiency Virus infection: p24 antigen detection, virus isolation and PCR analysis 176
Human bocavirus in Italian patients with respiratory diseases 176
Knowledge and attitudes of italian youth about AIDS. 174
DETECTION OF FELINE IMMUNODEFICIENCY VIRUS P24 ANTIGEN AND P24-SPECIFIC ANTIBODIES BY MONOCLONAL ANTIBODY-BASED ASSAYS 174
MALIGNANT-LYMPHOMA ASSOCIATED WITH EXPERIMENTALLY-INDUCED FELINE IMMUNODEFICIENCY VIRUS-INFECTION 173
Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients 170
AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viral replication following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus 170
Pre-infection with a poorly pathogenic FIV does not prevent infection by a fully virulent heterologous strain 169
Nefropatia associata ad infezione da "Feline Immunodeficiency virus" nel gatto domestico: un possibile modello animale per lo studio della nefropatia da HIV 163
Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use 162
Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro 160
Detection and in vivo localization of feline immunideficiency provirus by PCR in situ hybridization 158
Neuropathogenic potential of ORF-A truncated mutants of FIV-Petaluma 158
A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts 158
Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors 157
Blood borne hepatitis viruses: hepatitis viruses B, C, D, and candidate agents of cryptogenetic hepatitis 155
DECREASED HUMORAL AND CELL IMMUNITY IN MICE INFECTED WITH COXSACKIE-VIRUS 154
Az emberi 6-os herpeszvirus A valozata szolubilis mediatorok àaltal fokozza a HIV-1 szaporodàsàt in vitro, mely hàtast az endotoxin csokkenti = Human herpesvirus 6 variant A enhances in vitro HIV-1 replication by soluble mediators, the effect of which is diminished by indotoxin 153
DETECTION OF SALIVARY ANTIBODIES IN CATS INFECTED WITH FELINE IMMUNODEFICIENCY VIRUS 149
Perception of the AIDS problem by secondary school students in Italy. 148
Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine 148
Detection of feline immunodeficiency proviral sequences in lymphoid tissues and the central nervous system by in situ gene amplification 145
The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry 145
In vivo delivery of herpes simplex virus 1 glycoprotein B to vaccinate against genital herpes 144
In vivo delivery of herpes simplex type 1 glycoprotein B to vaccinate against genital herpes. 142
NEUTRALIZATION OF FRIEND LEUKEMIA-VIRUS BY SERA OF UNIMMUNIZED ANIMALS 141
A retro-inverso anologue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum 141
Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products 141
Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy 140
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans 139
AIDS VACCINATION STUDIES USING AN EX VIVO FELINE IMMUNODEFICIENCY VIRUS MODEL: DETAILED ANALYSIS OF THE HUMORAL IMMUNE RESPONSE TO A PROTECTIVE VACCINE 138
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: Protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine 138
Renal involvement in FIV-infection; p24 antigen detection, virus isolation and PCR analysis 138
High prevalence of TT virus viremia in Italian patients, regardless of age, clinical diagnosis, and previous interferon treatment 136
Anelloviruses and immune competence 136
Development of feline immunodeficiency virus ORF-A (tat) mutants: In vitro and in vivo characterization 136
Valutazione immunologica e clinica di emofilici italiani dopo 5 anni di sieropositività anti-HIV 135
Percezione del problema AIDS da parte di una popolazione studentesca 134
Immunolocalizzazione del virus dell'immunodeficienza felina (FIV) in tessuti di gatti infetti 132
I giovani e l'informazione sull'AIDS 131
Protein degradation and apoptotic death in lymphocytes during FIV infection. Activation of the ubiquitin-proteasome proteolytic system 131
Tumor Necrosis Factor Alpha and Virus Expression in the Central Nervous System in FIV-Infected Cats 129
Genetic and phylogenetic analyses of HIV-1 corroborate the transmission link hypothesis 129
TT virus in the nasal secretions of children with acute respiratory diseases: Relations to viremia and disease severity 127
Quantitative neuropathological assessment of FIV associated encephalopathy 126
Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats 126
Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus 125
Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification 125
NATURAL ANTIBODY-FORMING CELLS IN NORMAL MICE AND MICE INFECTED WITH FRIENDS LEUKEMIA-VIRUS COMPLEX 123
Immunobiology of the Torque teno viruses and other anelloviruses 123
TT virus and other anelloviruses 123
Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus 122
AIDS VACCINATION STUDIES USING AN EX VIVO FELINE IMMUNODEFICIENCY VIRUS MODEL: REEVALUATION OF NEUTRALIZING ANTIBODY LEVELS ELICITED BY A PROTECTIVE AND A NONPROTECTIVE VACCINE AFTER REMOVAL OF ANTI-SUBSTRATE CELL ANTIBODIES 122
Patologia epatica in corso d'infezione da virus dell'Immunodeficienza Felina (FIV) 121
Control of a virulent FIV challenge by an inactivated vaccine produced from virus engineered to express high levels of Env 119
Delayed hypersensitivity skin testing as a measure of cell-mediated immunity in FIV infected cats 118
Neuronal Damage Associated with FIV-Petaluma and FIV-PisaM2 Experimental Infection 117
Infezione da virus dell'immunideficienza felina (FIV): immunocomplessi circolanti ed analisi degli immunodepositi renali 113
Is torquetenovirus a potential cause of liver damage in children? 111
ANTIVIRAL ACTIVITY AND CONFORMATIONAL FEATURES OF AN OCTAPEPTIDE DERIVED FROM THE MEMBRANE-PROXIMAL ECTODOMAIN OF THE FELINE IMMUNODEFICIENCY VIRUS 111
Liver pathology in cats naturally and experimentally infected by FIV 109
Protezione da herpes genitale attraverso vaccinazione con glicoproteina B di herpes simplex di tipo 1. 108
Human anelloviruses and the central nervous system 108
Classification of hepatitis C virus type 2 isolates by phylogenetic analysis of core and NS5 regions 105
Anellovirus 105
ANALYSIS OF ROLE OF LYMPHATIC-LEUKEMIA VIRUS IN IMMUNODEPRESSION EXERTED BY FRIEND COMPLEX IN LEUKEMIA-RESISTANT C57BL-6 MICE 103
Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein 102
Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis 102
Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection 101
Development of TAT-deleted mutants of FIV and characterisation of their biological, pathogenic, and immunogenic properties 98
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’herpes genitale 97
Torquetenovirus (TTV) in Patients with Arthritis 96
Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. 91
Totale 15.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.098
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.098
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021466 0 0 0 0 0 22 52 86 62 59 33 152
2021/20221.279 57 77 23 135 234 146 14 69 36 55 66 367
2022/20231.849 204 237 99 219 188 255 17 98 320 7 194 11
2023/20241.091 201 118 189 69 139 183 39 27 19 6 9 92
2024/20253.226 9 116 20 171 415 348 277 192 236 440 413 589
2025/20262.088 276 429 410 244 408 321 0 0 0 0 0 0
Totale 15.466